Mesa Laboratories, Inc.
MLAB
$122.33
-$1.09-0.88%
| Weiss Ratings | MLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | D- | |||
| Rating Factors | MLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Weak | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | MLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.27 | |||
| Price History | MLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -11.07% | |||
| 30-Day Total Return | -13.90% | |||
| 60-Day Total Return | -3.99% | |||
| 90-Day Total Return | 7.54% | |||
| Year to Date Total Return | -7.19% | |||
| 1-Year Total Return | 23.15% | |||
| 2-Year Total Return | -27.23% | |||
| 3-Year Total Return | -50.93% | |||
| 5-Year Total Return | -35.22% | |||
| 52-Week High % Change | -21.14% | |||
| 52-Week Low % Change | 46.19% | |||
| Price | MLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $155.12 | |||
| 52-Week Low Price | $83.68 | |||
| 52-Week Low Price (Date) | Jun 27, 2024 | |||
| 52-Week High Price (Date) | Feb 10, 2025 | |||
| Valuation | MLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 664.69M | |||
| Enterprise Value | 844.01M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -46.26 | |||
| Earnings Per Share Growth | -27,716.36% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 2.79 | |||
| Price/Book (Q) | 4.28 | |||
| Enterprise Value/Revenue (TTM) | 3.55 | |||
| Price | $122.33 | |||
| Enterprise Value/EBITDA (TTM) | 19.99 | |||
| Enterprise Value/EBIT | 44.68 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | MLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 5.43M | |||
| Dividend Yield | 0.52% | |||
| Div. Per Share (Most Recent) | $0.16 | |||
| Dividend Per Share (TTM) | $0.64 | |||
| Payout Ratio (TTM) | -1.39% | |||
| Dividend Per Share (Most Recent) | $0.16 | |||
| Company Info | MLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 303 987 8000 | |||
| Address | 12100 West Sixth Avenue Lakewood, CO 80228 | |||
| Website | www.mesalabs.com | |||
| Country | United States | |||
| Year Founded | 1982 | |||
| Profitability | MLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 7.94% | |||
| Profit Margin | -104.91% | |||
| Management Effectiveness | MLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 2.00% | |||
| Return on Equity | -- | |||
| Income Statement | MLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 237.75M | |||
| Total Revenue (TTM) | 237.75M | |||
| Revenue Per Share | $43.79 | |||
| Gross Profit (TTM) | 151.06M | |||
| EBITDA (TTM) | 42.22M | |||
| EBIT (TTM) | 18.89M | |||
| Net Income (TTM) | -249.44M | |||
| Net Income Avl. to Common (TTM) | -249.44M | |||
| Total Revenue Growth (Q YOY) | 17.52% | |||
| Earnings Growth (Q YOY) | -179.21% | |||
| EPS Diluted (TTM) | -46.26 | |||
| EPS Diluted Growth (Q YOY) | -179.49% | |||
| Balance Sheet | MLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 32.29M | |||
| Cash Per Share (Q) | $5.95 | |||
| Total Current Assets (Q) | 110.85M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 155.21M | |||
| Current Ratio (Q) | 0.711 | |||
| Book Value Per Share (Q) | $28.57 | |||
| Total Assets (Q) | 437.15M | |||
| Total Current Liabilities (Q) | 155.88M | |||
| Total Debt (Q) | 211.61M | |||
| Total Liabilities (Q) | 281.93M | |||
| Total Common Equity (Q) | 155.21M | |||
| Cash Flow | MLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -3.07M | |||
| Cash from Financing (TTM) | -41.25M | |||
| Net Change in Cash (TTM) | 2.73M | |||
| Levered Free Cash Flow (TTM) | 50.02M | |||
| Cash from Operations (TTM) | 47.03M | |||
